Short-term safety and tolerability of antihypertensive agents in Korean patients: An observational study

Pharmacoepidemiology and Drug Safety

Volumn 9, Issue 7, 2000, Pages 603-609

  Kim, Young Sik ^a   Park, Hye Soon ^b   Sunwoo, Sung ^b   Byeon, Jai Jun ^b   Song, Yun Mi ^b   Seo, Hong Gwan ^b   Kim, Cheol Hwan ^b   Cheon, Kyeong Soo ^b   Yoo, Sun Mi ^b   Lee, Jung Kwon ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b NONE

Author keywords

blockers; blockers; Adverse reaction; Angiotensin converting enzyme inhibitors; Angiotensin II receptor antagonists; Antihypertensive agent; Calcium channel blocker; Diuretics; Tolerability

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; ARTICLE; CLINICAL OBSERVATION; CONSTIPATION; CONTROLLED STUDY; COUGHING; DRUG CLASSIFICATION; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; FLUSHING; GENDER; HEADACHE; HEART PALPITATION; HUMAN; IMPOTENCE; INCIDENCE; INDIGESTION; KOREA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUSCLE WEAKNESS; NAUSEA; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SEXUAL DYSFUNCTION; SHORT COURSE THERAPY; SIDE EFFECT; VERTIGO;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG TOLERANCE; FEMALE; HUMANS; KOREA; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0034458366     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.554     Document Type: Article

References (18)

1. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: Data from the Health Examination Surveys, 1960 to 1991
2. Evaluation, and Treatment of High Blood Pressure
3. Adverse reactions and interactions limiting the use of antihypertensive drugs
4. Managing hypertension in family practice: A nationwide collaborative study of the use of four antihypertensives in the treatment of mild-to-moderate hypertension
5. Antihypertensive drug side effects in the hypertension detection and follow-up program
6. Racial difference in incidence of cough with angiotension-converting inhibitors
7. Higher incidence of discontinuation of angiotension converting enzyme inhibitors due to cough in black subjects
8. Postmarketing surveillance for cough associated with angiotensin converting enzyme inhibitors
9. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors
10. Postmarketing surveillance of calcium channel blockers in hypertensive patients
11. Safety and tolerability of losartan patassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
12. Continuation of initial antihypertensive medication after 1 year of therapy
13. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: Efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril
14. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese
15. Effectiveness of nitrendipine, 20 mg once daily in the management of hypertension in general practice
16. Adverse reactions to antihypertensive therapy
17. Preliminary results of the Norwegian doxazosin postmarketing surveillance study: A twelve-week experience
18. Antihypertensive monotherapy with nitrendipine in general practice